Filing
3rd Quarter - Report
Lobbying activity
1
To promote Congressional awareness of the impact of healthcare policies on the research based biopharmaceutical and medical technology industry; monitor legislation related to drug prices and proposals related to tariffs on pharmaceutical products as well as domestic manufacturing